LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 71.78 | 27.76 | 6929 | 6893 | 1.0052 | 1.0013 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 71.78 | 27.76 | 1793 | 6893 | 0.2601 | 0.6886 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 71.78 | 27.76 | 9562 | 6893 | 1.3872 | 1.0840 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 73.48 | 27.76 | 2321 | 6957 | 0.3336 | 0.7426 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 73.48 | 27.76 | 7016 | 6957 | 1.0084 | 1.0021 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 73.48 | 27.76 | 2618 | 6957 | 0.3763 | 0.7692 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 73.48 | 27.76 | 9746 | 6957 | 1.4007 | 1.0864 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 75.19 | 27.76 | 2131 | 7015 | 0.3038 | 0.7227 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 75.19 | 27.76 | 7103 | 7015 | 1.0125 | 1.0031 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 75.19 | 27.76 | 2623 | 7015 | 0.3739 | 0.7681 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 75.19 | 27.76 | 9876 | 7015 | 1.4078 | 1.0876 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 76.89 | 27.76 | 2088 | 7025 | 0.2972 | 0.7180 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 76.89 | 27.76 | 7186 | 7025 | 1.0229 | 1.0057 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 76.89 | 27.76 | 5131 | 7025 | 0.7304 | 0.9228 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 76.89 | 27.76 | 10086 | 7025 | 1.4357 | 1.0927 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 78.60 | 27.76 | 1225 | 7045 | 0.1739 | 0.6066 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 78.60 | 27.76 | 7229 | 7045 | 1.0260 | 1.0064 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 78.60 | 27.76 | 5424 | 7045 | 0.7698 | 0.9356 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 78.60 | 27.76 | 10251 | 7045 | 1.4549 | 1.0961 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 80.31 | 27.76 | 813 | 6976 | 0.1165 | 0.5274 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 80.31 | 27.76 | 7269 | 6976 | 1.0420 | 1.0103 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 80.31 | 27.76 | 5433 | 6976 | 0.7788 | 0.9383 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 80.31 | 27.76 | 10401 | 6976 | 1.4909 | 1.1027 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 82.01 | 27.76 | 490 | 7000 | 0.0700 | 0.4331 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 82.01 | 27.76 | 7315 | 7000 | 1.0449 | 1.0111 | MN20160318_Q01 | F04 |